Nanorobotics in Medicine Market (Product Type: NanoManipulator, Bio-nanorobotics, Magnetically Guided, and Bacteria-based; and Application: Nanomedicine, Biomedical, Drug Delivery, Medical Imaging, and Others) - Global Industry Analysis, Size, Share, Grow

Nanorobotics in Medicine Market (Product Type: NanoManipulator, Bio-nanorobotics, Magnetically Guided, and Bacteria-based; and Application: Nanomedicine, Biomedical, Drug Delivery, Medical Imaging, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Nanorobotics in Medicine Market – Scope of Report

TMR’s report on the global nanorobotics in medicine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global nanorobotics in medicine market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nanorobotics in medicine market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the nanorobotics in medicine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nanorobotics in medicine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global nanorobotics in medicine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nanorobotics in medicine market.

The report delves into the competitive landscape of the global nanorobotics in medicine market. Key players operating in the global nanorobotics in medicine market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global nanorobotics in medicine market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market nanorobotics in medicine.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nanorobotics in Medicine Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nanorobotics in Medicine Market Analysis and Forecast, 2017 - 2031
5. Key Insights
5.1. Technological Advancements
5.2. Brand Analysis of Key Products
5.3. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global Nanorobotics in Medicine Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017 - 2031
6.3.1. Nanomanipulator
6.3.1.1. Electron Microscopy
6.3.1.2. Scanning Probe Microscopy
6.3.2. Bio-nanorobotics
6.3.3. Magnetically Guided
6.3.4. Bacteria-based
6.4. Market Attractiveness, by Product Type
7. Global Nanorobotics in Medicine Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017 - 2031
7.3.1. Nanomedicine
7.3.2. Biomedical
7.3.3. Drug Delivery
7.3.4. Medical Imaging
7.3.5. Others
7.4. Market Attractiveness, by Application
8. Global Nanorobotics in Medicine Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017 - 2031
8.3.1. Pharmaceutical Industry
8.3.2. Research Institute
8.3.3. Hospitals
8.3.4. Others
8.4. Market Attractiveness, by End-user
9. Global Nanorobotics in Medicine Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Nanorobotics in Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017 - 2031
10.2.1. Nanomanipulator
10.2.1.1. Electron Microscopy
10.2.1.2. Scanning Probe Microscopy
10.2.2. Bio-nanorobotics
10.2.3. Magnetically Guided
10.2.4. Bacteria-based
10.3. Market Value Forecast, by Application, 2017 - 2031
10.3.1. Nanomedicine
10.3.2. Biomedical
10.3.3. Drug Delivery
10.3.4. Medical Imaging
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017 - 2031
10.4.1. Pharmaceutical Industry
10.4.2. Research Institute
10.4.3. Hospitals
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017 - 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Nanorobotics in Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017 - 2031
11.2.1. Nanomanipulator
11.2.1.1. Electron Microscopy
11.2.1.2. Scanning Probe Microscopy
11.2.2. Bio-nanorobotics
11.2.3. Magnetically Guided
11.2.4. Bacteria-based
11.3. Market Value Forecast, by Application, 2017 - 2031
11.3.1. Nanomedicine
11.3.2. Biomedical
11.3.3. Drug Delivery
11.3.4. Medical Imaging
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017 - 2031
11.4.1. Pharmaceutical Industry
11.4.2. Research Institute
11.4.3. Hospitals
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Nanorobotics in Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017 - 2031
12.2.1. Nanomanipulator
12.2.1.1. Electron Microscopy
12.2.1.2. Scanning Probe Microscopy
12.2.2. Bio-nanorobotics
12.2.3. Magnetically Guided
12.2.4. Bacteria-based
12.3. Market Value Forecast, by Application, 2017 - 2031
12.3.1. Nanomedicine
12.3.2. Biomedical
12.3.3. Drug Delivery
12.3.4. Medical Imaging
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017 - 2031
12.4.1. Pharmaceutical Industry
12.4.2. Research Institute
12.4.3. Hospitals
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Nanorobotics in Medicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017 - 2031
13.2.1. Nanomanipulator
13.2.1.1. Electron Microscopy
13.2.1.2. Scanning Probe Microscopy
13.2.2. Bio-nanorobotics
13.2.3. Magnetically Guided
13.2.4. Bacteria-based
13.3. Market Value Forecast, by Application, 2017 - 2031
13.3.1. Nanomedicine
13.3.2. Biomedical
13.3.3. Drug Delivery
13.3.4. Medical Imaging
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017 - 2031
13.4.1. Pharmaceutical Industry
13.4.2. Research Institute
13.4.3. Hospitals
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Nanorobotics in Medicine Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017 - 2031
14.2.1. Nanomanipulator
14.2.1.1. Electron Microscopy
14.2.1.2. Scanning Probe Microscopy
14.2.2. Bio-nanorobotics
14.2.3. Magnetically Guided
14.2.4. Bacteria-based
14.3. Market Value Forecast, by Application, 2017 - 2031
14.3.1. Nanomedicine
14.3.2. Biomedical
14.3.3. Drug Delivery
14.3.4. Medical Imaging
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017 - 2031
14.4.1. Pharmaceutical Industry
14.4.2. Research Institute
14.4.3. Hospitals
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Imina Technologies SA
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Thermo Fisher Scientific, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Oxford Instruments plc
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Klocke Nanotechnik GmbH
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Kleindiek Nanotechnik GmbH
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. SmarAct GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Nanonics Imaging Ltd.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Hummingbird Scientific
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Hitachi, Ltd.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings